Two HLA-B27 subtypes, B'2702 and B'2705, both associated with ankylosing spondylitis, were tested for binding affinity with a panel of polyalanine model nonapeptides carrying Arg at position 2 (P2) and a series of different amino acids at position 9 (P9)\_ The alpha chains were isolated from BTB(B\*
The peptide-binding specificity of HLA-B27 subtype (B∗2705) analyzed by the use of polyalanine model peptides
✍ Scribed by Doriana Fruci; Giulia Greco; Eliana Vigneti; Nobuyuki Tanigaki; Richard H. Butler; Roberto Tosi
- Book ID
- 119145345
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 412 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0198-8859
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703 The results in this study address three aspects of peptide binding to the diseaseassociated antigen HLA-B27 and its modulation by polymorphism: the contribution of major anchor residues 2
High-affinity ligands of non-peptidic nature, binding to the class I major histocompatibility complex protein HLA B\*2705 whose expression is strongly linked to the pathogenesis of the autoimmune disease ankylosing spondylitis, should give way to a selective immunotherapy by blocking or antagonising
Previous studies indicated the increase of HLA-B39 among HLA-B27 negative patients with spondylarthropathies (SpA). This study was performed to examine whether the natural ligands of HLA-B27 are capable of binding to HLA-B39. Methods. Peptides were synthesized according to the sequences of known nat